Tradestie Institutional Equity Comparison Engine

IONS vs ZLAB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IONS Overall Edge

IONS Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ionis Pharmaceuticals, Inc. Common Stock (IONS) driven by superior Valuation, Growth & Margin while ZLAB counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, IONS trades at 90.9x Forward P/E with -58.8% operating margin (+54.9% YoY revenue) versus ZLAB at N/M Forward P/E and -63.0% operating margin (-6.8% YoY). In options structure, IONS sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against ZLAB sits in UNCLASSIFIED (58th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner IONS
IONS 90.9x vs ZLAB N/M Fwd P/E
Growth & Margin Winner IONS
Op Margin -58.8% vs -63.0% ยท YoY +54.9% vs -6.8%
Momentum & Technical Winner ZLAB
1Y -59.1% vs +9.2% ยท 52W Pos 2% vs 60%
Options & Structure Winner ZLAB
BREAKDOWN (17th %ile IV) vs UNCLASSIFIED (58th %ile IV)
IONS NASDAQ
Ionis Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$28.57
-1.7% 1D
Market Cap $4.7B
1M Return -33.48%
1Y Return -59.1%
Forward P/E 90.9x
Unified AI Score
63.9 / 100 BUY
Tech 60.0 Fund 63.0 Flow 73.0 Mom 55.0
ZLAB NASDAQ
Zai Lab Limited American Depositary Shares
Pharmaceutical Preparations
$23.74
-3.5% 1D
Market Cap $3.0B
1M Return +2.37%
1Y Return +9.25%
Forward P/E N/M
Unified AI Score
47.4 / 100 HOLD
Tech 25.0 Fund 39.0 Flow 50.0 Mom 53.5

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IONS -59.1% ZLAB +9.25% Spread: +68.35 pp (ZLAB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IONS TTM Op. Margin: -58.8% ZLAB TTM Op. Margin: -63.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IONS vs ZLAB. Trailing 12-month operating profitability (IONS -58.8% vs ZLAB -63.0%) and valuation multiples (IONS 90.9x vs ZLAB N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IONS (6) vs ZLAB (4)
Institutional Metric IONS ZLAB Criterion Row Winner
Market Capitalization Scale $4.7B $3.0B Larger Scale IONS
Trailing P/E Ratio Valuation 90.9x N/M Lower Multiple IONS
Forward P/E Ratio Valuation 90.9x N/M Lower Multiple IONS
Revenue Growth (YoY) Growth +54.9% -6.8% Higher Growth IONS
Operating Margin (TTM) Profitability -58.8% -63.0% Higher Margin IONS
Net Profit Margin Profitability -56.9% -44.9% Higher Margin ZLAB
Return on Equity (ROE) Capital Efficiency -108.0% -30.0% Higher ROE ZLAB
52-Week Range Position Momentum 2% ($27โ€“$87) 60% ($16โ€“$29) Stronger Trend ZLAB
Beta / 30D Volatility Risk Regime 0.18ฮฒ ยท 86% Vol 1.19ฮฒ ยท 78% Vol Lower Realized Risk ZLAB
Unified Institutional Score Composite Signal 63.9 / 100 (BUY) 47.4 / 100 (HOLD) Higher Composite IONS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IONS vs ZLAB Buy Guide
IONS BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live IONS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ZLAB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 58th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ZLAB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IONS nor ZLAB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.